Option Care Health (NASDAQ:OPCH) Now Covered by Analysts at TD Cowen

TD Cowen started coverage on shares of Option Care Health (NASDAQ:OPCH) in a research note published on Thursday morning, MarketBeat Ratings reports. The brokerage issued a hold rating and a $30.00 price objective on the stock.

A number of other brokerages have also issued reports on OPCH. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a report on Thursday, July 31st. Cowen started coverage on shares of Option Care Health in a report on Thursday. They issued a “hold” rating for the company. JMP Securities raised their target price on shares of Option Care Health from $36.00 to $38.00 and gave the company a “market outperform” rating in a report on Thursday, July 31st. Finally, Barrington Research reissued an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a report on Tuesday, September 23rd. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $35.11.

Option Care Health Trading Up 2.2%

Shares of OPCH opened at $27.84 on Thursday. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. Option Care Health has a 1 year low of $21.39 and a 1 year high of $35.53. The company has a 50 day simple moving average of $28.41 and a two-hundred day simple moving average of $30.89. The firm has a market cap of $4.52 billion, a P/E ratio of 22.27, a price-to-earnings-growth ratio of 1.65 and a beta of 0.88.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. During the same period last year, the firm posted $0.30 EPS. The company’s revenue was up 15.4% on a year-over-year basis. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, equities analysts expect that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the stock in a transaction that occurred on Wednesday, August 20th. The stock was bought at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the transaction, the director directly owned 375,390 shares in the company, valued at $10,191,838.50. This represents a 10.61% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Norman L. Wright purchased 3,411 shares of the stock in a transaction that occurred on Tuesday, September 9th. The stock was bought at an average price of $29.31 per share, with a total value of $99,976.41. Following the completion of the transaction, the director owned 15,501 shares of the company’s stock, valued at $454,334.31. The trade was a 28.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 59,411 shares of company stock worth $1,627,576 over the last three months. 0.64% of the stock is owned by insiders.

Institutional Trading of Option Care Health

Institutional investors have recently bought and sold shares of the stock. USA Financial Formulas bought a new stake in shares of Option Care Health during the second quarter worth $26,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Option Care Health by 1,492.9% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock worth $31,000 after purchasing an additional 836 shares during the last quarter. McIlrath & Eck LLC bought a new stake in shares of Option Care Health during the second quarter worth $37,000. Brooklyn Investment Group lifted its position in shares of Option Care Health by 186.6% during the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company’s stock worth $42,000 after purchasing an additional 780 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC bought a new stake in shares of Option Care Health during the second quarter worth $40,000. 98.05% of the stock is currently owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.